IRIS
GENTILE, Luca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.904
NA - Nord America 2.586
AS - Asia 1.892
SA - Sud America 611
AF - Africa 49
Continente sconosciuto - Info sul continente non disponibili 3
Totale 8.045
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.506
RU - Federazione Russa 926
SG - Singapore 855
BR - Brasile 523
IE - Irlanda 490
IT - Italia 483
CN - Cina 459
SE - Svezia 287
HK - Hong Kong 280
DE - Germania 192
PL - Polonia 139
FI - Finlandia 136
VN - Vietnam 101
IN - India 79
FR - Francia 64
GB - Regno Unito 63
CA - Canada 39
AR - Argentina 35
MX - Messico 30
AT - Austria 24
NL - Olanda 23
BE - Belgio 19
EC - Ecuador 19
ID - Indonesia 19
TR - Turchia 19
BD - Bangladesh 16
JP - Giappone 14
UA - Ucraina 14
ZA - Sudafrica 11
CI - Costa d'Avorio 10
ES - Italia 9
MA - Marocco 9
VE - Venezuela 8
IQ - Iraq 7
LT - Lituania 7
TN - Tunisia 7
CO - Colombia 6
CZ - Repubblica Ceca 6
PK - Pakistan 6
AZ - Azerbaigian 5
KE - Kenya 5
PE - Perù 5
PY - Paraguay 5
UZ - Uzbekistan 5
AE - Emirati Arabi Uniti 4
CL - Cile 4
RO - Romania 4
BO - Bolivia 3
EU - Europa 3
HN - Honduras 3
NP - Nepal 3
PH - Filippine 3
SK - Slovacchia (Repubblica Slovacca) 3
UY - Uruguay 3
BH - Bahrain 2
GR - Grecia 2
GT - Guatemala 2
KH - Cambogia 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
LV - Lettonia 2
MD - Moldavia 2
NI - Nicaragua 2
RS - Serbia 2
UG - Uganda 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
CH - Svizzera 1
CR - Costa Rica 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EG - Egitto 1
GN - Guinea 1
IL - Israele 1
IR - Iran 1
JM - Giamaica 1
JO - Giordania 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
LU - Lussemburgo 1
OM - Oman 1
PS - Palestinian Territory 1
PT - Portogallo 1
SA - Arabia Saudita 1
SN - Senegal 1
TG - Togo 1
TT - Trinidad e Tobago 1
Totale 8.045
Salva come PNG Salva come JPEG
Città #
Dublin 487
Moscow 477
Ashburn 449
Singapore 409
Dallas 376
Chandler 320
Hong Kong 276
Nyköping 217
Messina 189
Beijing 188
Warsaw 137
Munich 133
Princeton 73
Los Angeles 72
The Dalles 71
Helsinki 70
Medford 64
Ann Arbor 50
Des Moines 47
Buffalo 37
Jacksonville 37
São Paulo 37
New York 35
Turku 30
Pune 29
Wilmington 29
Ho Chi Minh City 27
Tianjin 25
Bremen 24
Dearborn 24
Redondo Beach 22
Hyderabad 20
Seattle 20
Cambridge 19
Lappeenranta 19
Belo Horizonte 18
Nuremberg 18
Palermo 17
Jinan 16
Rio de Janeiro 16
Boardman 15
Brussels 15
London 15
Brooklyn 14
Chicago 14
Hanoi 14
Redwood City 14
Chennai 13
Rome 13
Tokyo 13
Boston 12
Curitiba 12
Duncan 12
Falls Church 12
San Francisco 12
Santa Clara 12
Houston 11
Mexico City 11
Milan 11
Montreal 11
Vienna 11
Abidjan 10
Amsterdam 10
Brasília 10
Catania 10
Jakarta 10
Orem 10
Zhengzhou 10
Denver 9
Poplar 9
Porto Alegre 9
Campinas 8
Changsha 8
Dong Ket 8
Guayaquil 8
Ningbo 8
Shenyang 8
Frankfurt am Main 7
Haikou 7
Livorno 7
Manaus 7
Nanjing 7
Phoenix 7
San Mateo 7
Shanghai 7
Taizhou 7
Toronto 7
Ankara 6
Atlanta 6
Council Bluffs 6
Johannesburg 6
New Delhi 6
Woodbridge 6
Baghdad 5
Bagheria 5
Baku 5
Collegeville 5
Fortaleza 5
Goiânia 5
Guangzhou 5
Totale 5.177
Salva come PNG Salva come JPEG
Nome #
A NOVEL SERUM MICRORNA SIGNATURE TO SCREEN TRANSTHYRETIN-RELATED FAMILIAL AMYLOID POLYNEUROPATHY 317
6MWT performance correlates with peripheral neuropathy but not with cardiac involvement in patients with hereditary transthyretin amyloidosis (hATTR) 254
Diagnostic utility of Sudoscan for detecting Bortezomib-induced painful neuropathy 196
HATTR italian registry: preliminary data from the collaborative network of telethon GUP 15010 study 186
A Nouvel serum MicroRNA signature to screen ATTR 179
Circulating microRNAs Profile in Patients With Transthyretin Variant Amyloidosis 166
Monitoring effectiveness and safety of Tafamidis in transthyretin amyloidosis in Italy: a longitudinal multicenter study in a non-endemic area 165
Transthyretin-Related Familial Amyloid Polyneuropathy (TTR-FAP): A Single-Center Experience in Sicily, an Italian Endemic Area 157
Advances in Treatment of ATTRv Amyloidosis: State of the Art and Future Prospects 156
ATTRv amyloidosis Italian Registry: clinical and epidemiological data 132
Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study 129
Diagnosis of cardiac amyloid transthyretin (ATTR) amyloidosis by early (soft tissue) phase [99mTc]Tc-DPD whole body scan: comparison with late (bone) phase imaging 129
Chronic inflammatory demyelinating polyradiculoneuropathy: can a diagnosis be made in patients not fulfilling electrodiagnostic criteria? 128
Charcot-Marie-Tooth 2F: phenotypic presentation of the Arg136Leu HSP27 mutation in a multigenerational family 127
Cardiac 99mTc-DPD uptake in subjects with Glu89Gln transthyretin gene mutation: is it the earliest sign of disease development? 126
NfL as a biomarker in ATTRv amyloidosis: potential and limitations 123
Predicting needlestick and sharps injuries in nursing students: Development of the SNNIP scale 117
Prevalence and diagnostic value of extra-left ventricle echocardiographic findings in transthyretin-related cardiac amyloidosis 117
Novel outcome measures for Charcot-Marie-Tooth disease: Validation and reliability of the 6-min walk test and StepWatch™ Activity Monitor and identification of the walking features related to higher quality of life 112
Anxiety and depression in Charcot-Marie-Tooth disease: data from the Italian CMT national registry 112
Genetic neuromuscular disorders: living the era of a therapeutic revolution. Part 1: peripheral neuropathies 111
Phenotypic variability of TTR Val122Ile mutation: a Caucasian patient with axonal neuropathy and normal heart 105
Serial scanning with 99mTc-3, 3-diphosphono-1, 2-propanodicarboxylic acid (99mTc-DPD) for early detection of cardiac amyloid deposition and prediction of clinical worsening in subjects carrying a transthyretin gene mutation 103
Charcot-Marie-Tooth disease: experience from a large Italian tertiary neuromuscular center 98
A Cyst Compressing the Ulnar Nerve Motor Branch: Ultrasonographic Diagnosis of a Tricking Neuropathy. 98
Monitoring safety and effectiveness of tafamidis in transthyretin amyloidosis in italy. A 3-year longitudinal multicenter study in a non-endemic area. 96
"It is not what it seems." Ultrasound findings in a case of unusual iatrogenic ulnar nerve damage. 95
CMT subtypes in a cohort of italian patients enrolled at Messina neuromuscular centre since 1994 to 2014. 94
Use of the International Classification of Functioning, Disability and Health Generic-30 Set for the characterization of outpatients: Italian Society of physical and rehabilitative medicine residents section project 94
Subcutaneous immunoglobulin in CIDP and MMN: a different long-term clinical response? 93
Clinical and genotype characteristics and symptom migration in patients with mixed phenotype transthyretin amyloidosis from the transthyretin amyloidosis outcomes survey 91
Considerable post-partum worsening in a patient with CMT2E 91
A multicentre study on epidemiology and prevention of needle stick injuries among students of nursing schools 91
Patients' and physicians' interpretation of chemotherapy-induced peripheral neurotoxicity 91
Unilateral hyperhidrosis as persistently isolated feature of syringomyelia and Arnold Chiari type 1 90
Safety and tolerability of orally administered tafamidis meglumine in TTR FAP: preliminary data at 3-month follow-up 90
Nerve ultrasound in hereditary transthyretin amyloidosis: red flags and possible progression biomarkers 89
"Who seeks finds, who compares discovers". Usefulness of ultrasound to assess small nerve branches. 86
Description of a large cohort of Caucasian patients with V122I ATTRv amyloidosis: neurological and cardiological features 85
HATTR : Neurotrophic factors expression in schwann cell line after MIR-150 transfection. 83
A multicentric study of the disease risks and first manifestations in Hereditary transthyretin amyloidosis (ATTRv): insights for an earlier diagnosis 82
Diagnostic utility of Sudoscan for detecting bortezomib-induced painful neuropathy: a study on 18 patients with multiple myeloma 82
Relevance of diagnostic investigations in chronic inflammatory demyelinating poliradiculoneuropathy: data from the Italian CIDP database 82
"Seeing Through the Wall": Ultrasound Application for the Diagnosis and Treatment of Abdominal Pain. 81
Early detection of cardiac amyloid deposition in subjects with transthyretin gene mutation by 99mTc-disphosphonate scintigraphy 79
The THAOS: record of patients from our site. 79
Erratum to: Monitoring effectiveness and safety of Tafamidis in transthyretin amyloidosis in Italy: a longitudinal multicenter study in a non-endemic area (Journal of Neurology, DOI: 10.1007/s00415-016-8064-9) 79
Early detection of cardiac amyloid deposition in patients with transthyretin-related familial amyloid polyneuropathy by 99mTc-diphosphonate scintigraphy 76
Neurological data collection protocol on tafamidis meglumine treatment for familial amyloid polyneuropathy: preliminary data on patients enrolled by the italian network 75
Correction to: Diagnosis of cardiac amyloid transthyretin (ATTR) amyloidosis by early (soft tissue) phase [99mTc]Tc-DPD whole body scan: comparison with late (bone) phase imaging 74
Quantitative comparison between amyloid deposition detected by 99mTc-diphosphonate imaging and myocardial deformation evaluated by strain echocardiography in transthyretin related cardiac amyloidosis 74
Efficacy and quality of life in patients with multifocal motor neuropathy treated by subcutaneous immunoglobulin. 74
Very Early Onset of ATTRE89Q Amyloidosis in a Homozygous Patient 74
hATTR Pathology: Nerve Biopsy Results from Italian Referral Centers 74
A 15-year consolidated overview of data in over 6000 patients from the Transthyretin Amyloidosis Outcomes Survey (THAOS) 70
Frequency of diabetes and other comorbidities in chronic inflammatory demyelinating polyradiculoneuropathy and their impact on clinical presentation and response to therapy 70
Psychosocial burden and professional and social support in patients with hereditary transthyretin amyloidosis (ATTRv) and their relatives in Italy 70
Patisiran in hATTR Amyloidosis: Six-Month Latency Period before Efficacy 70
Transthyretin-related familial amyloidotic polyneuropathy: description of a cohort of patients with Leu64 mutation and late onset. 70
From a misdiagnosis of anorexia nervosa to a dramatic patisiran-induced improvement in a patient with ATTRE89Q amyloidosis 69
Impact of environmental factors and physical activity on disability and quality of life in CIDP 68
Use of drugs for ATTRv amyloidosis in the real world: How therapy is changing survival in a non-endemic area 68
Assessment of diagnostic criteria for multifocal motor neuropathy in patients included in the Italian database 67
Long-term treatment with subcutaneous immunoglobulin in patients with chronic inflammatory demyelinating polyradiculoneuropathy: a follow-up period up to 7 years 65
Clinical spectrum and frequency of Charcot-Marie-Tooth disease in Italy: data from the national CMT registry 64
Pregnancy in Charcot-Marie-Tooth disease: Data from the Italian CMT national registry 64
Comparison of the diagnostic accuracy of the 2021 EAN/PNS and 2010 EFNS/PNS diagnostic criteria for chronic inflammatory demyelinating polyradiculoneuropathy 63
Real-life experience with inotersen in hereditary transthyretin amyloidosis with late-onset phenotype: data from an early-access program in Italy 63
Long-term treatment of hereditary transthyretin amyloidosis with patisiran: multicentre, real-world experience in Italy 59
Subcutaneous immunoglobulin in CIDP and MMN: a short-term nationwide study 59
Ultrasound guidance increases diagnostic yield of needle EMG in plegic muscle. 59
Patisiran treatment in patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy after liver transplantation 58
Long-term treatment with subcutaneous immunoglobulin in multifocal motor neuropathy 58
TRPA1 rare variants in chronic neuropathic and nociplastic pain patients 56
TTR-FAP: a single-center experience in Sicily, an Italian endemic area 56
Long-term efficacy and safety of inotersen for hereditary transthyretin amyloidosis: NEURO-TTR open-label extension 3-year update 54
null 54
Phenotypic spectrum of myelin protein zero-related neuropathies: a large cohort study from five mutation clusters across Italy 53
Comparison of the diagnostic accuracy of the 2010 European Federation of Neurological Societies/Peripheral Nerve Society and American Association of Electrodiagnostic Medicine diagnostic criteria for multifocal motor neuropathy 52
Progressive brachial plexus enlargement in hereditary transthyretin amyloidosis 52
Prolonged distal motor latency of median nerve does not improve diagnostic accuracy for CIDP 52
Rare among rare: Phenotypes of uncommon CMT genotypes 51
Shear wave elastography of median nerve at wrist and forearm. Heterogeneity of normative values. 50
Use of Drugs for ATTRv Amyloidosis in the Real World: How Therapy Is Changing Survival in a Non-Endemic Area 48
Unclassified clinical presentations of chronic inflammatory demyelinating polyradiculoneuropathy 48
Phenotypic Differences of Glu89Gln Genotype in ATTR Amyloidosis From Endemic Loci: Update From THAOS 46
Impact of 2021 European Academy of Neurology/Peripheral Nerve Society diagnostic criteria on diagnosis and therapy of chronic inflammatory demyelinating polyradiculoneuropathy variants 45
Phenotypic characteristics of F64L, I68L, I107V, and S77Y ATTRv genotypes from the transthyretin amyloidosis outcomes survey (THAOS) 45
null 30
Frequency, entity and determinants of fatigue in Charcot-Marie-Tooth disease 28
Risk of disease relapse, safety and tolerability of SARS-CoV-2 vaccination in patients with chronic inflammatory neuropathies 28
Italian Real-Life Experience of Patients with Hereditary Transthyretin Amyloidosis Treated with Patisiran 26
Neuropathic pain experience in symptomatic and presymptomatic subjects carrying a transthyretin gene mutation 22
null 22
Use, tolerability, benefits and side effects of orthotic devices in Charcot-Marie-Tooth disease 22
Daytime sleepiness and sleep quality in Charcot-Marie-Tooth disease 20
Machine Learning for Early Diagnosis of ATTRv Amyloidosis in Non-Endemic Areas: A Multicenter Study from Italy 18
Patisiran in ATTRv amyloidosis with polyneuropathy: "PatisiranItaly" multicenter observational study 16
Serum neurofilament light chain: a promising early diagnostic biomarker for hereditary transthyretin amyloidosis? 16
The neurophysiological lesson from the Italian CIDP database 16
Totale 8.347
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.224
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.224
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021221 0 0 0 0 0 27 42 18 23 74 21 16
2021/2022474 14 48 3 16 40 11 48 28 16 22 31 197
2022/20231.280 106 115 78 76 86 114 19 61 570 13 27 15
2023/2024395 27 56 21 27 32 108 16 32 5 25 6 40
2024/20252.220 72 22 48 142 138 141 202 318 444 124 213 356
2025/20263.068 322 466 438 358 481 1.003 0 0 0 0 0 0
Totale 8.375